Article
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation - 1 Dec 2007
Reddy Anita J, Zaas Aimee K, Hanson Kimberly E, Palmer Scott M
Abstract excerpt
BACKGROUND: Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality after lung transplantation despite ganciclovir prophylaxis. The emergence of ganciclovir-resistant CMV in lung transplant patients has been reported, although the optimal strategy for the management of these inf...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
